Perspective Therapeutics (CATX) EBT Margin Growth (1y) (2011 - 2023)
Perspective Therapeutics (CATX) EBT Margin Growth (1y) (2011 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.33 Bn | 193.73 Bn | 7.27 Bn | -719.00 |
| 2 | Stryker | 126.56 Bn | 123.08 Bn | 4.50 Bn | 687.00 |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 458.00 |
| 4 | Boston Scientific | 73.11 Bn | 72.58 Bn | 3.85 Bn | 88.00 |
| 5 | Edwards Lifesciences | 52.09 Bn | 47.84 Bn | 1.35 Bn | 374.00 |
| 6 | Dexcom | 34.43 Bn | 32.48 Bn | 830.00 Mn | 343.00 |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 84.00 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -126.00 |
| 9 | Steris | 23.05 Bn | 22.57 Bn | 684.20 Mn | 165.00 |
| 10 | Perspective Therapeutics | 388.50 Mn | 388.50 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -33,302.00 |
| Jun 30, 2023 | -56,915.00 |
| Mar 31, 2023 | -48,066.00 |
| Sep 30, 2022 | -420.00 |
| Jun 30, 2022 | -7,661.00 |
| Mar 31, 2022 | 7,410.00 |
| Dec 31, 2021 | -897.00 |
| Sep 30, 2021 | -5,946.00 |
| Jun 30, 2021 | 7,571.00 |
| Mar 31, 2021 | -9,549.00 |
| Dec 31, 2020 | 1,162.00 |
| Sep 30, 2020 | 408.00 |
| Jun 30, 2020 | -539.00 |
| Mar 31, 2020 | 3,430.00 |
| Dec 31, 2019 | 1,518.00 |
| Sep 30, 2019 | 5,925.00 |
| Jun 30, 2019 | 9,319.00 |
| Mar 31, 2019 | 2,809.00 |
| Dec 31, 2018 | 2,280.00 |
| Sep 30, 2018 | 2,846.00 |